Imricor Medical Systems, Inc.
ASX:IMR.AX
1.74 (AUD) • At close May 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.959 | 0.616 | 0.816 | 0.696 | 0.702 | 0.64 | 1.343 | 0.566 | 0.704 |
| Cost of Revenue
| 1.884 | 1.731 | 2.343 | 2.592 | 1.1 | 0.377 | 0 | 0 | 0.215 |
| Gross Profit
| -0.924 | -1.116 | -1.527 | -1.896 | -0.398 | 0.262 | 1.343 | 0.566 | 0.489 |
| Gross Profit Ratio
| -0.963 | -1.813 | -1.871 | -2.723 | -0.566 | 0.41 | 1 | 1 | 0.695 |
| Reseach & Development Expenses
| 8.18 | 7.92 | 7.946 | 9.675 | 5.546 | 3.601 | 4.723 | 4.889 | 3.93 |
| General & Administrative Expenses
| 4.92 | 5.088 | 4.982 | 5.82 | 4.329 | 2.635 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 2.272 | 2.732 | 2.805 | 2.868 | 1.684 | 0.573 | 0 | 0 | 0 |
| SG&A
| 7.193 | 7.82 | 7.787 | 8.688 | 6.012 | 3.209 | 2.968 | 2.089 | 2.009 |
| Other Expenses
| 0 | -16.855 | 0.735 | 0.785 | 0.549 | 6.203 | 0 | 0 | 0 |
| Operating Expenses
| 16.14 | -1.116 | 16.468 | 19.148 | 12.107 | 13.013 | 7.69 | 6.978 | 5.939 |
| Operating Income
| -16.297 | -17.575 | -17.178 | -19.624 | -11.618 | -12.006 | -6.452 | -6.544 | -5.45 |
| Operating Income Ratio
| -16.986 | -28.551 | -21.052 | -28.184 | -16.546 | -18.768 | -4.805 | -11.569 | -7.742 |
| Total Other Income Expenses Net
| -13.396 | -5.051 | -0.178 | -0.109 | -0.829 | -1.288 | -0.845 | -0.167 | -0.045 |
| Income Before Tax
| -29.693 | -22.626 | -17.356 | -19.733 | -12.446 | -13.294 | -7.297 | -6.711 | -5.495 |
| Income Before Tax Ratio
| -30.949 | -36.756 | -21.27 | -28.34 | -17.726 | -20.781 | -5.435 | -11.865 | -7.806 |
| Income Tax Expense
| 0 | 0 | 0.178 | 0.824 | 0.63 | 1.504 | 0 | 0 | -0 |
| Net Income
| -29.693 | -22.626 | -17.534 | -20.556 | -13.077 | -14.798 | -7.297 | -6.711 | -5.495 |
| Net Income Ratio
| -30.949 | -36.756 | -21.488 | -29.523 | -18.624 | -23.133 | -5.435 | -11.865 | -7.806 |
| EPS
| -0.13 | -0.14 | -0.12 | -0.15 | -0.11 | -0.15 | -0.076 | -0.07 | -0.057 |
| EPS Diluted
| -0.13 | -0.14 | -0.12 | -0.15 | -0.11 | -0.15 | -0.076 | -0.07 | -0.057 |
| EBITDA
| -15.549 | -21.87 | -16.466 | -18.935 | -11.618 | -12.006 | -6.122 | -6.415 | -5.304 |
| EBITDA Ratio
| -16.206 | -35.529 | -20.178 | -27.194 | -16.546 | -18.768 | -4.56 | -11.342 | -7.535 |